S
Speciality Medicines Limited IPO
🟡 Allotment PhaseBSE SMESME IPOHealthcare
Issue Price
₹117–124
Issue Size
₹29.14 Cr
Lot Size
1200 shares
Min. Invest
₹149K
Open Date
20 Mar 2026
Close Date
24 Mar 2026
Allotment
25 Mar 2026
Listing Date
28 Mar 2026
75
IPOGenie Score
Subscribe
out of 100
Grey Market Premium
+₹22
+17.74% above issue price
Est. Listing₹146
GMP is unofficial — not regulated by SEBI.
IPOGenie Score — Speciality Medicines Limited
Our 5-factor scoring model: Financial Quality (30) + Subscription (25) + GMP (20) + Business (15) + Risk (10). Total: 75/100 — Subscribe.
Financial Quality26/30
Subscription Momentum20/25
GMP Sentiment13/20
Business Quality8/15
Risk Assessment8/10
This score is an analytical tool only, not investment advice. Consult a SEBI-registered advisor.
IPOGenie Market Signal🟢 Bullish
Solid fundamentals with GMP ₹22 (+17.7%). Score 75/100 — Subscribe.
Live Subscription Status
(Updated 2× daily from BSE+NSE)Overall4.80x
QIB (Qualified Institutional Buyers)3.20x
NII / HNI (Non-Institutional Investors)4.50x
RII (Retail Individual Investors)5.90x
Above 1x = oversubscribed. QIB subscription is the strongest institutional conviction signal.
GMP History — Speciality Medicines Limited
| Date | GMP (₹) | GMP (%) | Est. Listing | Trend |
|---|---|---|---|---|
| 24 Mar | +₹22 | 17.74% | ₹146 | — |
| 22 Mar | +₹22 | 17.74% | ₹146 | |
| 20 Mar | +₹15 | 12.10% | ₹139 | — |
IPOGenie Review — Speciality Medicines Limited
Niche B2B pharma manufacturer. Therapeutic focus: oncology, critical care, rare diseases. 200+ hospital pharmacy clients. Pan-India distribution via specialty pharma network.
Verdict: Subscribe. 17.7% GMP signals strong grey market demand. Niche focus means limited competition and better margins. Small issue size (Rs 29 crore) improves allotment odds.
Strengths
- 17.7% GMP — strong grey market demand
- Niche oncology/critical care with limited competition
- Small issue size improves allotment probability
Risks
- Very small company — post-listing liquidity risk
- Constant R&D investment required in specialty pharma
Speciality Medicines Limited IPO — Complete Details
| Open Date | 20 March 2026 |
| Close Date | 24 March 2026 |
| Allotment Date | 25 March 2026 |
| Listing Date | 28 March 2026 |
| Price Band | ₹117 – ₹124 per share |
| Face Value | ₹10 per share |
| Lot Size | 1200 shares |
| Min. Investment (Retail) | ₹1,48,800 |
| Issue Size | ₹29.14 Crores |
| Fresh Issue | ₹29.14 Crores |
| Offer for Sale (OFS) | None |
| Listing Exchange | BSE SME |
| IPO Type | SME IPO (NSE Emerge / BSE SME) |
| Issue Type | Book Built |
| Registrar | Bigshare Services Pvt Ltd |
| Lead Manager(s) | Beeline Capital Advisors Pvt Ltd |
| Promoter Holding (Pre-IPO) | 71.4% |
Speciality Medicines Limited — Financial Snapshot
Revenue
₹142 Cr
Net Profit (PAT)
₹18 Cr
EPS (Diluted)
₹8.4
P/E (Post-Issue)
14.76x
ROE
16.2%
ROCE
19.8%
Market Cap
₹175 Cr
Sector
Healthcare
Use of IPO Proceeds
- 1Capacity expansion: Rs 15 crore
- 2Working capital: Rs 8 crore
- 3General corporate purposes
IPO Documents
⚠️ Always read the RHP before investing — it contains all material risk factors and financial disclosures.
Frequently Asked Questions — Speciality Medicines Limited IPO
When does Speciality Medicines Limited IPO open and close?
Speciality Medicines Limited IPO opens on 20 March 2026 and closes on 24 March 2026. Allotment is expected on 25 March 2026 and listing on 28 March 2026.
What is the price band and lot size of Speciality Medicines Limited IPO?
Speciality Medicines Limited IPO price band is ₹117–₹124 per share. Lot size is 1200 shares. Minimum investment for retail investors is ₹1,48,800 (1 lot at cut-off price).
What is the GMP of Speciality Medicines Limited IPO today?
Speciality Medicines Limited IPO GMP (Grey Market Premium) today is ₹22 (+17.74%), suggesting an estimated listing price of ₹146. GMP is unofficial and not regulated by SEBI — use it as a sentiment indicator only.
How to check Speciality Medicines Limited IPO allotment status?
Check Speciality Medicines Limited IPO allotment status on the registrar website — Bigshare Services Pvt Ltd (https://bigshareonline.com). You can also check on BSE (bseindia.com → Investors → Application Status) using your PAN number. Allotment is finalised on 25 March 2026.
Is Speciality Medicines Limited IPO good for investment?
IPOGenie rates Speciality Medicines Limited IPO as "Subscribe" with a score of 75/100. Speciality Medicines manufactures niche pharmaceutical formulations in oncology supportive care, critical care, and rare disease segments where compet... Always read the RHP and consult a SEBI-registered advisor before investing.
How to apply for Speciality Medicines Limited IPO?
Apply for Speciality Medicines Limited IPO through: (1) UPI method — use any broker app (Zerodha, Groww, Upstox) and approve the UPI mandate. (2) ASBA — through your bank's net banking IPO section. Apply at cut-off price for best allotment odds. Maximum retail application is ₹2 lakh (1 lots).
What is the issue size of Speciality Medicines Limited IPO?
Speciality Medicines Limited IPO total issue size is ₹29.14 Cr. Fresh issue is ₹29.14 Cr.